Pseudoboehmite as a drug delivery system for acyclovir

Abstract Herpes simplex virus is among the most prevalent sexually transmitted infections. Acyclovir is a potent, selective inhibitor of herpes viruses and it is indicated for the treatment and management of recurrent cold sores on the lips and face, genital herpes, among other diseases. The problem...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Renato Meneghetti Peres, Jéssica Maiara Leme Sousa, Mariana Oliva de Oliveira, Maura Vincenza Rossi, Rene Ramos de Oliveira, Nelson Batista de Lima, Ayrton Bernussi, Juliusz Warzywoda, Bruno Sarmento, Antonio Hortencio Munhoz
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c2c6b9b5c16949c984dcb3a107312d1d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c2c6b9b5c16949c984dcb3a107312d1d
record_format dspace
spelling oai:doaj.org-article:c2c6b9b5c16949c984dcb3a107312d1d2021-12-02T18:47:04ZPseudoboehmite as a drug delivery system for acyclovir10.1038/s41598-021-94325-y2045-2322https://doaj.org/article/c2c6b9b5c16949c984dcb3a107312d1d2021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94325-yhttps://doaj.org/toc/2045-2322Abstract Herpes simplex virus is among the most prevalent sexually transmitted infections. Acyclovir is a potent, selective inhibitor of herpes viruses and it is indicated for the treatment and management of recurrent cold sores on the lips and face, genital herpes, among other diseases. The problem of the oral bioavailability of acyclovir is limited because of the low permeability across the gastrointestinal membrane. The use of nanoparticles of pseudoboehmite as a drug delivery system in vitro assays is a promising approach to further the permeability of acyclovir release. Here we report the synthesis of high purity pseudoboehmite from aluminium nitrate and ammonium hydroxide containing nanoparticles, using the sol–gel method, as a drug delivery system to improve the systemic bioavailability of acyclovir. The presence of pseudoboehmite nanoparticles were verified by infrared spectroscopy, transmission electron microscopy, and X-ray diffraction techniques. In vivo tests were performed with Wistar rats to compare the release of acyclovir, with and without the addition of pseudoboehmite. The administration of acyclovir with the addition of pseudoboehmite increased the drug content by 4.6 times in the plasma of Wistar rats after 4 h administration. We determined that the toxicity of pseudoboehmite is low up to 10 mg/mL, in gel and the dried pseudoboehmite nanoparticles.Renato Meneghetti PeresJéssica Maiara Leme SousaMariana Oliva de OliveiraMaura Vincenza RossiRene Ramos de OliveiraNelson Batista de LimaAyrton BernussiJuliusz WarzywodaBruno SarmentoAntonio Hortencio MunhozNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Renato Meneghetti Peres
Jéssica Maiara Leme Sousa
Mariana Oliva de Oliveira
Maura Vincenza Rossi
Rene Ramos de Oliveira
Nelson Batista de Lima
Ayrton Bernussi
Juliusz Warzywoda
Bruno Sarmento
Antonio Hortencio Munhoz
Pseudoboehmite as a drug delivery system for acyclovir
description Abstract Herpes simplex virus is among the most prevalent sexually transmitted infections. Acyclovir is a potent, selective inhibitor of herpes viruses and it is indicated for the treatment and management of recurrent cold sores on the lips and face, genital herpes, among other diseases. The problem of the oral bioavailability of acyclovir is limited because of the low permeability across the gastrointestinal membrane. The use of nanoparticles of pseudoboehmite as a drug delivery system in vitro assays is a promising approach to further the permeability of acyclovir release. Here we report the synthesis of high purity pseudoboehmite from aluminium nitrate and ammonium hydroxide containing nanoparticles, using the sol–gel method, as a drug delivery system to improve the systemic bioavailability of acyclovir. The presence of pseudoboehmite nanoparticles were verified by infrared spectroscopy, transmission electron microscopy, and X-ray diffraction techniques. In vivo tests were performed with Wistar rats to compare the release of acyclovir, with and without the addition of pseudoboehmite. The administration of acyclovir with the addition of pseudoboehmite increased the drug content by 4.6 times in the plasma of Wistar rats after 4 h administration. We determined that the toxicity of pseudoboehmite is low up to 10 mg/mL, in gel and the dried pseudoboehmite nanoparticles.
format article
author Renato Meneghetti Peres
Jéssica Maiara Leme Sousa
Mariana Oliva de Oliveira
Maura Vincenza Rossi
Rene Ramos de Oliveira
Nelson Batista de Lima
Ayrton Bernussi
Juliusz Warzywoda
Bruno Sarmento
Antonio Hortencio Munhoz
author_facet Renato Meneghetti Peres
Jéssica Maiara Leme Sousa
Mariana Oliva de Oliveira
Maura Vincenza Rossi
Rene Ramos de Oliveira
Nelson Batista de Lima
Ayrton Bernussi
Juliusz Warzywoda
Bruno Sarmento
Antonio Hortencio Munhoz
author_sort Renato Meneghetti Peres
title Pseudoboehmite as a drug delivery system for acyclovir
title_short Pseudoboehmite as a drug delivery system for acyclovir
title_full Pseudoboehmite as a drug delivery system for acyclovir
title_fullStr Pseudoboehmite as a drug delivery system for acyclovir
title_full_unstemmed Pseudoboehmite as a drug delivery system for acyclovir
title_sort pseudoboehmite as a drug delivery system for acyclovir
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/c2c6b9b5c16949c984dcb3a107312d1d
work_keys_str_mv AT renatomeneghettiperes pseudoboehmiteasadrugdeliverysystemforacyclovir
AT jessicamaiaralemesousa pseudoboehmiteasadrugdeliverysystemforacyclovir
AT marianaolivadeoliveira pseudoboehmiteasadrugdeliverysystemforacyclovir
AT mauravincenzarossi pseudoboehmiteasadrugdeliverysystemforacyclovir
AT reneramosdeoliveira pseudoboehmiteasadrugdeliverysystemforacyclovir
AT nelsonbatistadelima pseudoboehmiteasadrugdeliverysystemforacyclovir
AT ayrtonbernussi pseudoboehmiteasadrugdeliverysystemforacyclovir
AT juliuszwarzywoda pseudoboehmiteasadrugdeliverysystemforacyclovir
AT brunosarmento pseudoboehmiteasadrugdeliverysystemforacyclovir
AT antoniohortenciomunhoz pseudoboehmiteasadrugdeliverysystemforacyclovir
_version_ 1718377704179367936